Inhibition of human T-lymphotropic virus type I gene expression by the Streptomyces-derived substance EM2487

Antiviral Chemistry and Chemotherapy

Volumn 13, Issue 3, 2002, Pages 177-183

  Wang, X ^a   Okamoto, M ^a   Kawamura, M ^a   Izumo, S ^b   Baba, M ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

EM2487; HAM TSP; HTLV I; Tax; Transcription

Indexed keywords

ANTIVIRUS AGENT; EM 2487; MESSENGER RNA; TAX PROTEIN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; ORGANOPHOSPHATE; URIDINE;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; STREPTOMYCES; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL DIVISION; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MONONUCLEAR CELL; TRANSACTIVATION; VIROLOGY;

ANTIVIRAL AGENTS; CELL DIVISION; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAX; GENES, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR; MOLECULAR STRUCTURE; PARAPARESIS, TROPICAL SPASTIC; PHOSPHORIC ACID ESTERS; STREPTOMYCES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; URIDINE; VIRUS REPLICATION;

EID: 2342514340     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020201300304     Document Type: Article

References (29)

1. Baba M, Okamoto M, Kawamura M, Makino M, Higashida T, Takashi T, Kimura Y, Ikeuchi T, Tetsuka T & Okamota T (1998) Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives. Molecular Pharmacology 53:1097-1103.
2. Baba M, Okamoto M &Takeuchi H (1999) Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a streptomyces species. Antimicrobial Agents and Chemotherapy 43:2350-2355.
3. Bieganowska K, Hollsberg P, Buckle GJ, Lim DG, Greten TF, Schneck J, Altman JD, Jacobson S, Ledis SL, Hanchard B, Chin J, Morgan O, Roth PA & Hafler DA (1999) Direct analysis of viral-specific CD8-T cells with soluble HLA-A2/Tax 11-19 tetramer complexes in patients with human T cell lymphotropic virus- associated myelopathy. Journal of Immunology 162:1765-1771.
4. Bogerd HP, Fridell RA, Madore S & Cullen BR (1995) Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485-494.
5. Bogerd HP, Echarri A, Ross TM & Cullen BR (1998) Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. Journal of Virology 72:8627-8635.
6. Cann AJ & Chen ISY (1996) Human T-Cell Leukemia Virus Type I and II. In Fields Virology, Third Edition. Edited by BN Fields, DM Knipe, PM Howley, et al. Philadelphia: Lippincott-Raven, pp. 1849-1880.
7. Chen ISY, Slamon DJ, Rosenblatt JD, Shah NP, Quan SG & Wachsman W (1985) The x gene is essential for HTLV replication. Science 229:54-58.
8. De Rossi A, Aldovini A, Franchini G, Mann D, Gallo RC & Wong-Staal F (1985) Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type I: parameters of virus integration and expression. Virology 143:640-645.
9. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F & Pavlakis GN (1985) The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229:675-679.
10. Franchini G (1995) Molecular mechanism of human T-cell leukemia/lymphotropic virus type I infection. Blood 86:3619-3639.
11. tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate- responsive elements. Journal of Virology 63:3234-3239.
12. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A & de-The G (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
13. Hidaka M, Inoue J, Yoshida M & Seiki M (1988) Post-transcriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. European Molecular Biology Organization Journal 7:519-523.
14. x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proceedings of the National Academy of Sciences USA 84:3653-3657.
15. Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y & Goto I (1992) Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. Journal of the Neurological Sciences 107:98-104.
16. Lofters W, Campbell M, Gibbs WN & Cheson BD (1987) 2′-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma. Cancer 60:2605-2608.
17. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K & Hinuma Y. (1981) Detection of type C particles in a cord T-cell line derived by cocultivating normal human leukemia T-cells. Nature 294:770.
18. Miyoshi I, Taguchi H, Kubonisho I, Yoshimoto S, Ohtsuki Y, Shiraishi Y & Akagi T (1982) Type C virus-producing cell lines derived from adult T cell leukemia. Japanese Journal of Cancer Research 28:219-228.
19. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S & Osame M (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. Journal of Neurovirology 4:586-593.
20. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M & Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet i:1031-1032.
21. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J & De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods 20:309-321.
22. Takenouchi N, Matsumoto E, Moritoyo T, Nagai M, Katsuta K, Hasui K, Ueno K, Eizuru Y, Usuku K, Osame M, Isashiki Y & Izumo S (1999) Molecular pathologic analysis of the tonsil in HTLV-I-infected individuals. Journal of Acquired Immune Deficiency Syndromes 22:200-207.
23. Takeuchi H, Asai N, Tanabe K, Kozaki T, Fujita M, Sakai T, Okuda A, Naruse N, Yamamoto S, Sameshima T, Heida N, Dobashi K & Baba M (1999) EM2487, a novel anti-HIV-1 antibiotic, produced by Streptomyces sp. Mer-2487: Taxonomy, fermentation, biological properties, isolation and structure elucidation. The Journal of Antibiotics 52:971-982.
24. Tanaka Y, Yoshida A, Takayama Y, Tsujimoto H, Tsujimoto A, Hayami M & Tozawa H (1990) Heterogeneity of antigen molecules recognized by anti-Taxi monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retrovirus. Japanese Journal of Cancer Research 81:225-231.
25. Taylor GP, Hall SE, Navarete S, Michie CA, Davis R, Witkover AD, Rossor M, Nowak MA, Rudge P, Matutes E, Bangham CRM & Weber JN (1999) Effect of lamivudine on human T-cell, leukemia virus type I (HTLV-I) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-I- associated myelopathy. Journal of Virology 73:10289-10295.
26. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K & Uchino H. (1977) Adult T-cell Leukemia: Clinical and Hematologic Features of 16 Cases. Blood 50:481-492.
27. Vernant JC, Maurs L, Gessain A, Barin F, Gout O, Delaporte JM, Sanhadji K, Buisson G & de-The G (1987) Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Annals of Neurology 21:123-130.
28. Wang X, Miyake H, Okamoto M, Saito M, Fujisawa J, Tanaka Y, Izumo S & Baba M (2002) Inhibition of the Tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinoline derivative K-37. Molecular Pharmacology 61:1359-1365.
29. Yoshida M (1987) Expression of the HTLV-I genome and its association with a unique T-cell malignancy. Biochimica et Biophysics Acta 907:145-161.